20 noviembre 2014
Blocking molecules involved in ALS-drug resistance may improve how well ALS therapeutics work, suggesting that re-evaluation of drugs that appeared to have failed might be appropriate.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/w0GIlRWstvs/141120081750.htm
